BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.65 0.0  0.0%

Last Trade - 6:35pm

Sector
Healthcare
Size
Small Cap
Market Cap £254.5m
Enterprise Value £227.7m
Revenue £112.6m
Position in Universe 3926th / 6846

BRIEF-Endo International says U.S. FDA approves BELBUCA buccal film for chronic pain management

Mon 26th October, 2015 10:00am
Oct 26 (Reuters) - Endo International PLC  ENDP.O : 
 * U.S. FDA approves Belbuca(TM) (buprenorphine) buccal film for chronic pain 
   management 
 * Belbuca(TM) is expected to be commercially available in the U.S during the 
   first quarter of 2016 
 * FDA approval of Belbuca(TM) was based on two double-blind, randomized, 
   placebo-controlled, enriched-enrollment phase 3 studies 
 
 * Source text for Eikon  ID:nCNW8933Ka  
 
 * Further company coverage  ENDP.O   
 ((Bengaluru Newsroom; +1 646 223 8780))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.